Review for "Romidepsin treatment for relapsed or refractory peripheral and cutaneous T‐cell lymphoma ‐ real‐life data from a national multicenter observational study"

2019 ◽  
Author(s):  
Luigi Rigacci
Keyword(s):  
T Cell ◽  
Observational Study ◽  
Cell Lymphoma ◽  
Real Life ◽  
T Cell Lymphoma ◽  
Cutaneous T Cell Lymphoma ◽  
Multicenter Observational Study ◽  
Life Data ◽  
Real Life Data

Romidepsin treatment for relapsed or refractory peripheral and cutaneous T‐cell lymphoma: Real‐life data from a national multicenter observational study

2019 ◽  
Vol 37 (5) ◽  
pp. 569-577
Author(s):  
Shai Shimony ◽  
Netanel Horowitz ◽  
Elena Ribakovsky ◽  
Uri Rozovski ◽  
Abraham Avigdor ◽  
...  
Keyword(s):  
T Cell ◽  
Observational Study ◽  
Cell Lymphoma ◽  
Real Life ◽  
T Cell Lymphoma ◽  
Cutaneous T Cell Lymphoma ◽  
Multicenter Observational Study ◽  
Life Data ◽  
Real Life Data

Real life data on advanced cutaneous T cell lymphoma patients treated with brentuximab vedotin: results from a multicenter European EORTC study

2019 ◽  
Vol 119 ◽  
pp. S34-S35
Author(s):  
E. Papadavid ◽  
V. Pappa ◽  
E. Kapniari ◽  
V. Nikolaou ◽  
T. Hliakis ◽  
...  
Keyword(s):  
T Cell ◽  
Cell Lymphoma ◽  
Real Life ◽  
Brentuximab Vedotin ◽  
T Cell Lymphoma ◽  
Cutaneous T Cell Lymphoma ◽  
Life Data ◽  
Real Life Data

Cutaneous T-Cell Lymphoma Incidence Rising

2008 ◽  
Vol 39 (6) ◽  
pp. 15
Author(s):  
BRUCE JANCIN
Keyword(s):  
T Cell ◽  
Cell Lymphoma ◽  
T Cell Lymphoma ◽  
Cutaneous T Cell Lymphoma
Sign in / Sign up

Export Citation Format

Share Document